Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
about
New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisonsDabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of SubgroupsAnticoagulation in atrial fibrillation: NOAC's the wordHow we treat bleeding associated with direct oral anticoagulantsEdoxaban in venous thromboembolism and stroke prevention: an appraisalNovel oral anticoagulants and the 73rd anniversary of historical warfarinThe evolution of anticoagulant therapyRisk of Fatal Bleeding in Episodes of Major Bleeding with New Oral Anticoagulants and Vitamin K Antagonists: A Systematic Review and Meta-AnalysisAntithrombotic management of atrial fibrillation in the elderlyClinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation - patient considerationsReversal of target-specific oral anticoagulantsA Patient With Asymptomatic Cerebral Lesions During AF Ablation: How Much Should We Worry?Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesA decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients.Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014.A standardized bleeding risk score aligns anticoagulation choices with current evidence.Use of novel oral anticoagulant agents in atrial fibrillation: current evidence and future perspective.Management of acute stroke in patients taking novel oral anticoagulants.Diabetes and atrial fibrillation: stratification and prevention of stroke risks.Reversal of novel oral anticoagulants in patients with major bleeding.Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.Approach to the new oral anticoagulants in family practice: part 1: comparing the options.Novel oral anticoagulants in non-valvular atrial fibrillation.Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for StrokeInterrupting anticoagulation in patients with nonvalvular atrial fibrillation.Managing the information boundary of an organization: key aspect of translating research into practiceComparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD.Bleeding risk and mortality of edoxaban: a pooled meta-analysis of randomized controlled trials.New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials.Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis.Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? No.Target-specific oral anticoagulants: should we switch from warfarin?Bleeding complications from the direct oral anticoagulants.Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT).Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort studyAnticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective coComparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke.
P2860
Q21132464-A09B47A8-C0EC-471D-BCEF-40F3CDD39C63Q21284803-F1037787-BB6E-4D7C-AF1B-E13983A06E8FQ24618605-AC77F7B1-0130-4056-9517-61B60C4F0A0EQ26748343-E170D907-B84D-409D-B67B-258E8139157DQ26751263-37D0CEFC-C81E-4501-83A6-FC4AE60FA4D7Q26771544-46A6C962-0E0E-46EC-B47E-2D85C346DB7BQ26771859-88085CEF-97C1-4CE2-9577-95067ED0D49EQ26783473-5514C6FF-0088-4C0C-BA36-CF043CF4236AQ26827113-80C3C635-E734-466E-9E71-908040040B12Q27000967-53C3362F-B86B-4C6A-9801-E898A0107C7BQ27003866-AD00DC2C-140F-4986-B544-46090755F05CQ28077388-1EB719A0-E2FE-43BD-8AB1-94E857E784F5Q28078747-5EE3EDBF-2B8E-44AD-81E7-DE4A40BF3709Q33440651-81F37D83-15EC-4816-8DA5-E0328439A36AQ33565534-2995ACEC-9E84-4A62-B2C4-733411D19205Q33956677-3616F9FA-09CF-4C3F-BBD8-982498AC268FQ34099930-21628838-B9C1-4512-BCC4-F1D753723A44Q34111320-12E6262D-55EF-460A-B62B-048B2436BD77Q34307896-77A393AC-AF1D-425F-AD8A-A8C651A5B199Q34326655-856A8308-2427-42FA-9B8F-52B3460622ACQ34469002-A0203296-E4A5-4102-A26A-FCF3145C4085Q34497581-6328FBF6-24D1-4596-AFEF-AC9436BCEA64Q34666804-455E4057-1205-4CF9-8EE1-095CC54B2135Q34670524-BA5E7A86-500F-4450-AE70-5998989AF2BFQ34688742-140E3D6C-B1A1-4183-99FA-3758D848B270Q35067769-38A7C4D3-410E-4765-97BA-62EACEEB3E36Q35079761-21C9D240-ABDD-4725-8931-6A3AD4CF1D3AQ35149499-7C5A33E3-E973-46EC-B5C9-8B5CEEBE79B9Q35160888-2230F32F-A991-4B9A-82E5-67C8CAFF9530Q35235448-B7A2E370-0B1A-4789-A99A-BD390D6213E3Q35681742-BF179CE4-A9E9-4ABC-97E3-3EED8C1E11C7Q35689817-EDFAF502-9587-411B-8111-DE5B916DF9C3Q35758778-29452EC0-EA83-41D2-9F55-324D480667A4Q35878677-4AA157EA-DCE9-4F4E-9D9F-3DC388EA1E11Q36012558-A27E7443-9334-4616-964E-BAFBDCB07B09Q36063155-6C78DBCE-817C-4DAD-ACE0-FB74529BBD87Q36085794-80FF63AB-A24B-4B11-B83F-111533BA2C01Q36112493-E5667264-639C-4311-B28A-6D7C0C4AEC96Q36153857-C50CD29A-BB3D-4118-9250-E8AAC214C9A2Q36155695-321145D2-0877-48F0-9F21-FB94ABA50826
P2860
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy and safety of the nov ...... ta-analysis of the literature.
@en
type
label
Efficacy and safety of the nov ...... ta-analysis of the literature.
@en
prefLabel
Efficacy and safety of the nov ...... ta-analysis of the literature.
@en
P2093
P921
P1433
P1476
Efficacy and safety of the nov ...... eta-analysis of the literature
@en
P2093
Alexander G G Turpie
Francesco Dentali
Gregory Y H Lip
Mark Crowther
P304
P356
10.1161/CIRCULATIONAHA.112.115410
P407
P577
2012-10-15T00:00:00Z